How often should a 1-year-old child receive Polytrim (polymyxin B/trimethoprim) eye drops for bacterial conjunctivitis (pink eye)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Polytrim Dosing for 1-Year-Old with Bacterial Conjunctivitis

For a 1-year-old with bacterial conjunctivitis, administer Polytrim (polymyxin B/trimethoprim) eye drops 1 drop in the affected eye(s) four times daily for 7 days.

Dosing Regimen

The standard dosing for Polytrim in pediatric bacterial conjunctivitis is:

  • Frequency: 4 times daily (approximately every 4-6 hours while awake)
  • Duration: 7 days
  • Dose: 1 drop per affected eye

This regimen is supported by multiple clinical trials demonstrating efficacy in children 1, 2, 3. The four-times-daily dosing has been validated in randomized controlled trials specifically including pediatric patients as young as 1 year old 1, 2.

Clinical Context and Evidence

Mild to moderate bacterial conjunctivitis in children typically responds well to broad-spectrum topical antibiotics. The 2024 Conjunctivitis Preferred Practice Pattern guidelines note that bacterial conjunctivitis is usually self-limited but that topical antibacterial therapy is associated with earlier clinical and microbiological remission, particularly in days 2-5 of treatment 4. Treatment also reduces transmissibility and allows for earlier return to daycare or school 4.

Comparative Effectiveness

While newer fluoroquinolones like moxifloxacin may achieve faster symptom resolution (81% cure at 48 hours vs 44% with Polytrim) 1, Polytrim remains highly effective with 96% clinical cure rates by 7-10 days 2. A 2013 randomized trial in children ages 1-18 years demonstrated no statistical difference in final cure rates between moxifloxacin and Polytrim (95% vs 96%, respectively) 2. Given the significant cost difference and equivalent final outcomes, Polytrim continues to be a first-line choice 2.

Important Clinical Considerations

Follow-up timing: Advise parents to return if no improvement is noted within 3-4 days 4. Most cases should show significant improvement by 48-72 hours.

Red flags requiring immediate reassessment:

  • Copious purulent discharge with marked inflammation (suggests possible gonococcal infection requiring systemic antibiotics) 4
  • Corneal involvement or opacity
  • Severe pain beyond mild discomfort
  • Vision changes
  • Age-specific concern: In any child, consider the possibility of more serious pathogens if presentation is severe 4

Administration Technique

Instruct caregivers to:

  • Wash hands before and after administration
  • Tilt child's head back or lay child down
  • Pull lower eyelid down gently to create a pocket
  • Instill 1 drop without touching the dropper tip to the eye or eyelid
  • Have child close eyes gently for 1-2 minutes
  • Wipe away excess with clean tissue

Avoid contamination: Do not share bottles between family members, and avoid touching the dropper tip to any surface 5.

Duration and Completion

Complete the full 7-day course even if symptoms resolve earlier to ensure microbiological eradication and reduce risk of recurrence. Studies consistently used 7-day treatment courses 1, 2, 6, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.